<DOC>
	<DOCNO>NCT02627911</DOCNO>
	<brief_summary>The study conduct crossover trial , two 72-hour hospitalization separate period Wash-out least one week . Each hospitalization period treatment . According randomization , patient provide either Diabeloop system usual system . In treatment period : - patient situation sedentarity physical activity , equip ActiGraph ( measure motricity ) ActiHeart ( measure heart rate ) - meal physical activity similar period - blood glucose meter use throughout duration study . - capillary blood glucose perform : bolus 2 hour meal , exercise , case hypo hyper-glycemic episode patient / investigator deem necessary .</brief_summary>
	<brief_title>Diabeloop WP6.2 : Crossover Evaluation Glycemic Control</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetic patient least one year , treat external insulin pump least 6 month Patient 7.5 % &lt; HbA1c &lt; 9.5 % Patient practice functional insulin therapy In situation physical activity , patient must able perform one daily physical activity 3 day treatment session Patient age 18 year Patient affiliate Social Security Patient agree participate study sign informed consent Type 2 diabetic patient Any serious illness may impair study participation* Patient insulin resistance define insulin requirement &gt; 1.5 U / kg / day Patient longer sense hypoglycemia Patient enjoying measure legal protection Pregnant woman likely</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>